CIBC World Markets Inc. Has $2.58 Million Holdings in Mylan (MYL)
CIBC World Markets Inc. lifted its stake in Mylan (NASDAQ:MYL) by 59.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 60,935 shares of the company’s stock after acquiring an additional 22,813 shares during the period. CIBC World Markets Inc.’s holdings in Mylan were worth $2,578,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently modified their holdings of the company. Meeder Asset Management Inc. lifted its stake in shares of Mylan by 76.9% in the 3rd quarter. Meeder Asset Management Inc. now owns 3,393 shares of the company’s stock worth $106,000 after acquiring an additional 1,475 shares during the period. BT Investment Management Ltd acquired a new stake in shares of Mylan in the 3rd quarter worth approximately $142,000. Advisor Partners LLC acquired a new stake in shares of Mylan in the 4th quarter worth approximately $214,000. First Personal Financial Services lifted its stake in shares of Mylan by 77.1% in the 4th quarter. First Personal Financial Services now owns 4,839 shares of the company’s stock worth $205,000 after acquiring an additional 2,106 shares during the period. Finally, Mycio Wealth Partners LLC acquired a new stake in shares of Mylan in the 4th quarter worth approximately $212,000. 75.10% of the stock is owned by institutional investors.
In other news, CEO Heather M. Bresch sold 75,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $45.00, for a total transaction of $3,375,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.69% of the stock is owned by insiders.
Mylan (NASDAQ:MYL) last released its earnings results on Monday, November 6th. The company reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.20 by ($0.10). Mylan had a return on equity of 20.63% and a net margin of 7.28%. The business had revenue of $2.99 billion during the quarter, compared to the consensus estimate of $3.09 billion. During the same quarter in the previous year, the firm earned $1.38 earnings per share. The firm’s revenue for the quarter was down 2.3% compared to the same quarter last year. analysts predict that Mylan will post 4.55 earnings per share for the current fiscal year.
MYL has been the subject of a number of research analyst reports. Zacks Investment Research lowered shares of Mylan from a “buy” rating to a “hold” rating in a research note on Wednesday, November 8th. Cantor Fitzgerald set a $34.00 price target on shares of Mylan and gave the stock a “hold” rating in a research note on Tuesday, October 31st. Guggenheim initiated coverage on shares of Mylan in a research note on Tuesday, December 12th. They issued a “buy” rating and a $59.00 price target for the company. Citigroup reaffirmed a “buy” rating and issued a $58.00 price target (up from $48.00) on shares of Mylan in a research note on Thursday, January 4th. Finally, Leerink Swann initiated coverage on shares of Mylan in a research note on Tuesday, January 2nd. They issued a “market perform” rating and a $44.00 price target for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $44.65.
COPYRIGHT VIOLATION NOTICE: “CIBC World Markets Inc. Has $2.58 Million Holdings in Mylan (MYL)” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/cibc-world-markets-inc-has-2-58-million-holdings-in-mylan-myl/1843499.html.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.